1994
DOI: 10.1001/archneur.1994.00540200048015
|View full text |Cite
|
Sign up to set email alerts
|

Clinical Correlates of Cortical and Nucleus Basalis Pathology in Alzheimer Dementia

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
50
0

Year Published

1998
1998
2009
2009

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 136 publications
(52 citation statements)
references
References 39 publications
2
50
0
Order By: Relevance
“…In addition to cell death of basal forebrain neurons, neuropathology also develops in the basal forebrain with Alzheimer's disease. Neuropathology in the basal forebrain seems to be highly correlated with scores on tests for memory ability, whereas loss of cortical synapses was strongly correlated with scores on tests for cognitive ability (Samuel et al, 1994). Neuropathology in the cholinergic basal forebrain precedes cortical volume loss and cholinergic cell loss, suggesting that changes to cholinergic neurons are a primary event (Cullen et al, 1997).…”
Section: Memory Storage and Agingmentioning
confidence: 98%
“…In addition to cell death of basal forebrain neurons, neuropathology also develops in the basal forebrain with Alzheimer's disease. Neuropathology in the basal forebrain seems to be highly correlated with scores on tests for memory ability, whereas loss of cortical synapses was strongly correlated with scores on tests for cognitive ability (Samuel et al, 1994). Neuropathology in the cholinergic basal forebrain precedes cortical volume loss and cholinergic cell loss, suggesting that changes to cholinergic neurons are a primary event (Cullen et al, 1997).…”
Section: Memory Storage and Agingmentioning
confidence: 98%
“…Although senile plaques and neurofibrillary tangles (NFTs) in the brain are considered the pathological hallmarks, the presences of these hallmarks seem not correlated to the severity of dementia (Arriagada, et al, 1992, Samuel, et al, 1994, Gomez-Isla, et al, 1997. In contrast, neuronal loss in certain selected brain regions represents a direct pathological cause for dementia (Bondareff, et al, 1982, Whitehouse, et al, 1982, Samuel, et al, 1994, Gomez-Isla, et al, 1997, Bussiere, et al, 2003. Furthermore, the hippocampus is one of the most vulnerable brain regions to AD, and the degeneration in this brain structure may directly underlie memory deficit, the earliest symptom of AD (Barber, et al, 2001, Thompson, et al, 2004.…”
Section: Introductionmentioning
confidence: 99%
“…Some authors suggest that the accumulation and deposition of A␤ peptides and the subsequent formation of senile plaques are the primary cause of neurodegeneration and behavioral changes in AD patients (Kisilevsky and Fraser, 1997;Selkoe, 2001;Hardy and Selkoe, 2002). Several studies, however, have indicated that A␤ plaque burden does not correlate with dementia in patients (Arriagada et al, 1992;Samuel et al, 1994;McLean et al, 1999), and investigations using murine AD models have so far been unable to provide a clear answer to this question. Therefore, although nobiletin reduces A␤ plaque pathology and improves cognitive deficits in a transgenic mouse model of AD, it is not determined whether a reduction in A␤ production or deposition is responsible for the improvement of cognitive deficits by nobiletin.…”
mentioning
confidence: 99%